AAA
Affinity Asset Advisors Portfolio holdings
AUM
$676M
This Quarter Return
+1.26%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$234M
AUM Growth
+$234M
(-6.7%)
Cap. Flow
+$12.8M
Cap. Flow
% of AUM
5.45%
Top 10 Holdings %
Top 10 Hldgs %
48.19%
Holding
87
New
8
Increased
17
Reduced
10
Closed
28
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$10.7M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$9.29M |
| 3 |
Protagonist Therapeutics
PTGX
|
$8.25M |
| 4 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$7.84M |
| 5 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$6.09M |
Top Sells
| 1 |
Ocular Therapeutix
OCUL
|
$7.5M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$6.08M |
| 3 |
Ascendis Pharma
ASND
|
$5.72M |
| 4 |
Travere Therapeutics
TVTX
|
$4.66M |
| 5 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$3.6M |
Sector Composition
| 1 | Healthcare | 88.12% |
| 2 | Financials | 5.84% |
| 3 | Real Estate | 0% |
